AEON
AEON Biopharma·AMEX
--
--(--)
--
--(--)
AEON Filings
Filing Date
Form Description
Form Type
2026-02-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-02-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-02-18
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-18 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-18
Form EFFECT - Notice of Effectiveness
2026-02-18 ·
Form EFFECT - Notice of Effectiveness
2026-02-09
Form S-3 - Registration statement under Securities Act of 1933
2026-02-09 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-01-29
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-29 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-29
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2026-01-29 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2026-01-29
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-01-29 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-01-21
Form 8-K - Current report
Key Events
2026-01-21 · Key Events
Form 8-K - Current report
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2025-12-29
Form DEF 14A - Other definitive proxy statements
Key Events
2025-12-29 · Key Events
Form DEF 14A - Other definitive proxy statements
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
